Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic

Clinical trial NCT01643278 · COMPLETED

Trial details

NCT number: NCT01643278
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumor Stage III Soft Tissue Sarcoma Stage IV Soft Tissue Sarcoma

Start date: 2012-07-01
Primary completion: 2016-06-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.